Proto Script Pharmaceutical
(OTC) PSCR
Proto Script Pharmaceutical Financials at a Glance
Market Cap
$11.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$604.98K
Net Income (TTM)
-$8.39M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
28.03 (High)
Dividend
$0.00
Beta (Volatility)
28.03 (High)
Price
$0.00
Volume
100
Open
$0.00
Price
$0.00
Volume
100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
28.03 (High)
Price
$0.00
Volume
100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
N/A
PSCR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Proto Script Pharmaceutical
Industry
Healthcare Providers and Services
Sector
Health CareHeadquarters
Rancho Cucamonga, CA 91730, US
PSCR Financials
Key Financial Metrics (TTM)
Gross Margin
71.55%
Operating Margin
-37.78%
Net Income Margin
-910.40%
Return on Equity
5578.94%
Return on Capital
N/A
Return on Assets
-4220.39%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.83%
Stock Overview
Market Cap
$11.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
56.90M
Volume
100
Avg. Volume
235.484
Financials (TTM)
Gross Profit
$351.81K
Operating Income
-$970.95K
EBITDA
-$845.20K
Operating Cash Flow
-$303.10K
Capital Expenditure
-$33.85K
Free Cash Flow
-$336.94K
Cash & ST Invst.
$0.00
Total Debt
$372.75K
Proto Script Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$251.97K
+17.8%
Gross Profit
$213.78K
+22.6%
Gross Margin
84.84%
N/A
Market Cap
$11.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$876.92
N/A
Employees
13
N/A
Net Income
-$283.65K
-190471.1%
EBITDA
-$163.56K
-11892.0%
Quarterly Fundamentals
Total Cash
$0.00
-100.0%
Total Debt
$372.75K
+353.3%
Accounts Receivable
$166.44K
-32.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$372.75K
+353.3%
Return on Assets
-42.20%
N/A
Return on Invested Capital
93.23%
N/A
Free Cash Flow
-$24.90K
+39.6%
Operating Cash Flow
-$24.30K
+36.4%